These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15167989)

  • 1. The impact of compliance with osteoporosis therapy on fracture rates in actual practice.
    Caro JJ; Ishak KJ; Huybrechts KF; Raggio G; Naujoks C
    Osteoporos Int; 2004 Dec; 15(12):1003-8. PubMed ID: 15167989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population.
    Huybrechts KF; Ishak KJ; Caro JJ
    Bone; 2006 Jun; 38(6):922-8. PubMed ID: 16330270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States.
    Cheng LI; Durden E; Limone B; Radbill L; Juneau PL; Spangler L; Mirza FM; Stolshek BS
    J Manag Care Spec Pharm; 2015 Sep; 21(9):824-33, 833a. PubMed ID: 26308229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with drug therapies for the treatment and prevention of osteoporosis.
    McCombs JS; Thiebaud P; McLaughlin-Miley C; Shi J
    Maturitas; 2004 Jul; 48(3):271-87. PubMed ID: 15207894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with osteoporosis drug therapy and risk of fracture.
    Weycker D; Macarios D; Edelsberg J; Oster G
    Osteoporos Int; 2007 Mar; 18(3):271-7. PubMed ID: 17021945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and consequences of noncompliance to oral bisphosphonate treatment.
    Eisenberg DF; Placzek H; Gu T; Krishna A; Tulsi BB
    J Manag Care Spec Pharm; 2015 Jan; 21(1):56-65. PubMed ID: 25562773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fracture and osteoporosis clinic: 1-year results and 3-month compliance.
    Blonk MC; Erdtsieck RJ; Wernekinck MG; Schoon EJ
    Bone; 2007 Jun; 40(6):1643-9. PubMed ID: 17433805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: a retrospective case-control analysis.
    Cotté FE; Mercier F; De Pouvourville G
    Clin Ther; 2008 Dec; 30(12):2410-22. PubMed ID: 19167600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the comparative effectiveness of 3 oral bisphosphonates in a large managed care organization: adherence, fracture rates, and all-cause cost.
    Martin KE; Yu J; Campbell HE; Abarca J; White TJ
    J Manag Care Pharm; 2011 Oct; 17(8):596-609. PubMed ID: 21942301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis.
    Halpern R; Becker L; Iqbal SU; Kazis LE; Macarios D; Badamgarav E
    J Manag Care Pharm; 2011; 17(1):25-39. PubMed ID: 21204588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.
    Gold DT; Martin BC; Frytak JR; Amonkar MM; Cosman F
    Curr Med Res Opin; 2007 Mar; 23(3):585-94. PubMed ID: 17355739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up for osteoporosis in older patients three years after a fracture.
    Schurink M; Hegeman JH; Kreeftenberg HG; Ten Duis HJ
    Neth J Med; 2007 Feb; 65(2):71-4. PubMed ID: 17379932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
    Ward A; Ishak K; Proskorovsky I; Caro J
    Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures.
    Bliuc D; Eisman JA; Center JR
    Osteoporos Int; 2006; 17(9):1309-17. PubMed ID: 16804739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate therapy for osteoporosis: combining optimal fracture risk reduction with patient preference.
    Beard MK
    Curr Med Res Opin; 2012 Jan; 28(1):141-7. PubMed ID: 22103779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis.
    Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B
    J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical activity slows femoral bone loss but promotes wrist fractures in postmenopausal women: a 15-year follow-up of the OSTPRE study.
    Rikkonen T; Salovaara K; Sirola J; Kärkkäinen M; Tuppurainen M; Jurvelin J; Honkanen R; Alhava E; Kröger H
    J Bone Miner Res; 2010 Nov; 25(11):2332-40. PubMed ID: 20533310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of bisphosphonate therapy in a community setting.
    Feldstein AC; Weycker D; Nichols GA; Oster G; Rosales G; Boardman DL; Perrin N
    Bone; 2009 Jan; 44(1):153-9. PubMed ID: 18926939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.